NCRI Press Release, 8 November 2010
Date published: Nov 08 2010
Test selects 60 per cent of women with inherited ovarian cancer who could benefit from ‘smart’ drug
Download the attachment
Recent Tweets
-
October is #BreastCancerAwareness Month! Many sessions at #NCRI2019 will use #breastcancerresearch as an exemplar… https://t.co/ZAOyqviM3N
6 hours ago -
Have a look at what @plummer_ruth , co-chair of #NCRI2019, said about last year's Conference. Hurry up - standard… https://t.co/36SumSsOvK
1 day ago -
More people are living with and beyond cancer, including incurable #SecondaryBreastCancer. We will be focussing on… https://t.co/9PKDOsi76u
1 day ago
- 19 Sep 2019Head of Business Operations (NCRI) vacancy
- 19 Jul 2019Consumer (Patient / Carers) vacancies for NCRI Groups available. Apply today!
- 18 Jun 2019Register now for the NCRI Annual Lymphoma UK Trials Meeting: 1 November 2019
- 20 May 2019Celebrating ten years of NCRI’s Clinical and Translational Radiotherapy Research Group
- 29 Apr 2019NCRI and The British Society for Immunology announce new partnership
- 14 Mar 2019Register now for the NCRI CTU Annual Trials Meeting: 17 June 2019
RSS Feed